Infarct restraint to limit adverse ventricular remodeling

Area of Science:

• Cardiovascular Research
• Biomedical Engineering
• Regenerative Medicine

Background:

• Myocardial infarction (MI) triggers complex biomechanical changes in the left ventricle.
• Infarct expansion, or stretching, leads to ventricular dilatation and contractile dysfunction, causing heart failure.
• Limiting infarct expansion is a key therapeutic target to mitigate adverse ventricular remodeling.

Purpose of the Study:

• To review experimental evidence on the role of infarct expansion in post-MI remodeling.
• To present proof-of-concept studies on early mechanical infarct restraint strategies.
• To highlight the potential of novel biomaterial-based therapies for limiting infarct expansion.

Main Methods:

• Review of experimental studies demonstrating the importance of infarct expansion.
• Discussion of ventricular restraint using polymeric mesh wraps placed early after MI.
• Presentation of data on injected acellular biomaterials to modify infarct properties and geometry.

Main Results:

• Experimental work confirms infarct expansion's central role in post-MI remodeling.
• Early mechanical infarct restraint, including wraps, is effective in limiting ventricular remodeling.
• Injected biomaterials show efficacy in altering infarct properties and reducing remodeling.

Conclusions:

• Limiting infarct expansion is a critical therapeutic strategy to prevent heart failure progression after MI.
• Early mechanical interventions, such as polymeric wraps and injected biomaterials, offer promising approaches.
• Minimally invasive, catheter-based technologies for infarct modification represent a potential future treatment.